stoxline Quote Chart Rank Option Currency Glossary
  
Tilray Brands, Inc. (TLRY)
6.95  -0.27 (-3.74%)    03-12 16:00
Open: 7.145
High: 7.215
Volume: 2,414,308
  
Pre. Close: 7.22
Low: 6.93
Market Cap: 704(M)
Technical analysis
2026-03-12 4:18:32 PM
Short term     
Mid term     
Targets 6-month :  9.04 1-year :  9.7
Resists First :  7.74 Second :  8.31
Pivot price 7.47
Supports First :  6.82 Second :  5.68
MAs MA(5) :  7.18 MA(20) :  7.5
MA(100) :  9.68 MA(250) :  8.57
MACD MACD :  -0.3 Signal :  -0.3
%K %D K(14,3) :  23.2 D(3) :  30
RSI RSI(14): 36.5
52-week High :  23.2 Low :  3.5
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ TLRY ] has closed above bottom band by 9.1%. Bollinger Bands are 67.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 23 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 7.46 - 7.49 7.49 - 7.52
Low: 7.08 - 7.12 7.12 - 7.16
Close: 7.15 - 7.22 7.22 - 7.28
Company Description

Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.

Headline News

Thu, 12 Mar 2026
Tilray Expands German Healthcare Push With Strategic Pharma Deal - Benzinga

Thu, 12 Mar 2026
Tilray gains preferred access to over 20% of German pharmacies - Stock Titan

Wed, 11 Mar 2026
Tilray (TLRY) Launches New Light Beer to Refresh Brand Offerings - GuruFocus

Wed, 11 Mar 2026
Lighter. Cheaper. Funner. Pub Light Is Here. - markets.businessinsider.com

Wed, 11 Mar 2026
Tilray Brands Launches Pub Light: A New Easy-Drinking American-Style Light Lager - Quiver Quantitative

Mon, 09 Mar 2026
Tilray Brands (TLRY) going strong amid diversification into beverages and spring products launch - MSN

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Shares Out 117 (M)
Shares Float 116 (M)
Held by Insiders 0.7 (%)
Held by Institutions 10.4 (%)
Shares Short 14,850 (K)
Shares Short P.Month 15,170 (K)
Stock Financials
EPS -23.54
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 14.89
Profit Margin -251.7 %
Operating Margin -9.2 %
Return on Assets (ttm) -1.6 %
Return on Equity (ttm) -84.2 %
Qtrly Rev. Growth 3 %
Gross Profit (p.s.) 2.01
Sales Per Share 7.18
EBITDA (p.s.) 0.19
Qtrly Earnings Growth 0 %
Operating Cash Flow -28 (M)
Levered Free Cash Flow 31 (M)
Stock Valuations
PE Ratio -0.3
PEG Ratio 0
Price to Book value 0.46
Price to Sales 0.96
Price to Cash Flow -28.47
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android